Cargando...
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines
Abstract Background All-trans retinoic acid (ATRA) is currently being used to treat hematological malignancies, given the ability to inhibit cell proliferation. This effect seems to be related to epigenetic changes of the TERT (Telomerase Reverse Transcriptase) promoter. When hypomethylated, ATRA-in...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
BMC
2019-07-01
|
Colección: | Journal of Ovarian Research |
Materias: | |
Acceso en línea: | http://link.springer.com/article/10.1186/s13048-019-0536-y |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|